ABSTRACT

Fact Sheet for Healthcare Providers: Fluidigm Corporation Advanta Dx SARS-CoV-2 RT-PCR Assay   [open pdf - 142KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Advanta Dx SARS-CoV-2 RT-PCR [severe acute respiratory syndrome coronavirus 2 real time polymerase chain reaction] Assay. The Advanta Dx SARS-CoV-2 RT-PCR Assay is authorized for use with saliva specimens collected from individuals suspected of COVID-19 [coronavirus disease 2019] by their healthcare provider."

Publisher:
Date:
2020-08-25
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations